Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.670
+0.180 (5.16%)
Aug 4, 2026, 1:38 PM EDT - Market open
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $15.57 million as of August 4, 2026. Its market cap has increased by 86.96% in one year.
Market Cap
15.57M
Enterprise Value
11.98M
1-Year Change
86.96%
Ranking
Category
Stock Price
$3.67
ChartMarket Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $15.57M, a decrease of -91.95%. That is a compound annual growth rate of -28.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 15.57M | 222.01% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OSR Health | 15.73M |
| Citius Pharmaceuticals | 15.65M |
| Pasithea Therapeutics | 15.37M |
| NextCure | 14.97M |
| Vyome Holdings | 14.84M |
| Passage Bio | 14.34M |
| KALA BIO | 14.05M |
| Moolec Science | 14.00M |